ALB and pharynx cancer: In contrast, we found a lower risk of cancer in the salivary glands per SD increase in neutrophils in % (HR: 0.41; 95%CI: 0.22-079), PLR (HR: 0.57; 95%CI: 0.34-0.96), and NLR (HR: 0.49; 95%CI: 0.26-0.92), a lower risk of cancer in the nose and middle ear per SD increase in albumin (HR: 0.81; 95%CI: 0.66-0.99), as well as a lower risk of pharynx cancer per SD increase in lymphocytes in % (HR: 0.59; 95%CI: 0.43-0.82).